Molecular Diagnostics on the Rise

What’s the fastest-growing field in the laboratory medicine industry? If you ask five different people, you may well get five different answers – but one thing is for sure: there is an escalating demand for competent and accurate diagnostic methods. And for those who desire the most precise and personalized medicine possible, molecular diagnostics are key.

The expansion of the molecular pathology industry won’t be solely down to patient demand, though. Market researchers have also seen widespread product acceptance for applications including infection identification, patient stratification, drug regimen selection and therapeutic monitoring, and more. Because any error in diagnosis or treatment can have severe repercussions, pathologists and laboratory medicine professionals need accurate, safe, and dependable diagnostic tools – and this is where molecular diagnostics has the opportunity to shine.

Genetic disorders and infectious diseases must be diagnosed early and accurately, not only to provide efficient treatment, but also because late detection can give rise to further complications. In terms of the reliability and rapid response time required for early intervention, traditional diagnostic approaches fall significantly short. As a result, the molecular diagnostics market is expecting significant growth (1).

Molecular Diagnostics in 2024